12:00 AM
May 19, 2014
 |  BC Week In Review  |  Company News  |  Sales & Marketing

Genfa Medica, MediWound sales and marketing update

MediWound granted Genfa exclusive rights to market and distribute NexoBrid in Russia to treat severe burns. MediWound said it expects...

Read the full 90 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >